CRBP logoCRBP
Corbus Pharmaceuticals Holdings Inc

21,519
Loading...
Loading...
News
all
press releases
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?
Zacks·4mo ago
News Placeholder
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
Study enrolling patients with metastatic urothelial cancer (mUC) and other Nectin-4 enriched tumorsEmerging clinical profile from CSPC's Phase 1 China study indicates differentiation from PADCEV...
Globe Newswire·1y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $37.79) entered Downtrend as Momentum indicator drops below 0 level on Mar 21, 2024
This indicator may be signaling that CRBP's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·1y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $38.81) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 20, 2024
This is a Bearish indicator signaling CRBP's price could decline from here. Traders may explore shorting the stock or put options...
Tickeron - Stocks·1y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $44.79) RSI Indicator left the overbought zone on March 14, 2024
This is a signal that CRBP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·1y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $47.08) RSI Indicator left the overbought zone on March 13, 2024
This is a signal that CRBP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·1y ago
News Placeholder
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Encouraging CRB-701 (SYS6002) First-in-Human Data Presented at ASCO-GU 2024; first patient expected to be dosed in US Ph1 study by end of March 2024 IND Application for CRB-601 cleared; Ph1...
Globe Newswire·1y ago
News Placeholder
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Major Shareholder Cormorant Asset Management, Lp Buys 250,000 Shares of Stock
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP Get Free Report) major shareholder Cormorant Asset Management, Lp bought 250,000 shares of the stock in a transaction that occurred on...
Zolmax·1y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $38.27) RSI Indicator left the overbought zone on March 11, 2024
This is a signal that CRBP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·1y ago

Latest CRBP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.